Cite
MLA Citation
Liqin Sun et al.. “Higher Risk of Dyslipidemia With Coformulated Elvitegravir, Cobicistat, Emtricitabine, and Tenofovir Alafenamide than Efavirenz, Lamivudine, and Tenofovir Disoproxil Fumarate Among Antiretroviral-Naive People Living With HIV in China.” Journal of acquired immune deficiency syndromes, vol. 91, n.d., pp. S8–S15. http://access.bl.uk/ark:/81055/vdc_100167545972.0x000009